CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Revenue

In the year 2025, CStone Pharmaceuticals had annual revenue of 269.58M CNY, down -33.80%. CStone Pharmaceuticals had revenue of 220.13M in the half year ending December 31, 2025, with 8.78% growth.

• Revenue: 269.58M CNY
• Revenue Growth: -33.80%
• P/S Ratio: 50.21
• Revenue / Employee: 1.98M CNY
• Employees: 136
• Market Cap: 15.06B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	269.58M	-137.62M	-33.80%
Dec 31, 2024	407.21M	-56.64M	-12.21%
Dec 31, 2023	463.84M	-17.52M	-3.64%
Dec 31, 2022	481.36M	237.65M	97.51%
Dec 31, 2021	243.72M	-795.11M	-76.54%